In the news · GLP-1 and weight-loss drugs

Is a bootleg weight-loss drug to blame for 2 reported deaths?

Headline from cbsnews.com

CBS News reports that the FDA received two reports of deaths, in July and September, after people took bootleg products claiming to be retatrutide, an experimental Eli Lilly weight-loss drug not approved by the FDA. CBS could not verify the reports, and it is unclear whether the drug was to blame. America's Poison Centers logged 862 exposures to retatrutide in the three months ending in September.

Why it matters: Relevant to Maryland adults considering medical weight loss, and the clinicians who refer them, as unapproved weight-loss drugs are being sold online.

Read the full story at cbsnews.com →

A summary of another publisher's reporting, written with AI and checked automatically against the story. The reporting belongs to cbsnews.com. October 13, 2026.

AthleticsMD Clinical Desk

Today's front page

The newest articles and the day's news on GLP-1 & weight loss, Metabolic health, Hormones and more.

Go to the front page →